Entera Bio Statistics

Total Valuation

Entera Bio has a market cap or net worth of $61.25 million. The enterprise value is $52.44 million.

Market Cap	61.25M
Enterprise Value	52.44M

Important Dates

The next estimated earnings date is Friday, August 9, 2024, after market close.

Earnings Date	Aug 9, 2024
Ex-Dividend Date	n/a

Share Statistics

Entera Bio has 35.82 million shares outstanding. The number of shares has increased by 27.51% in one year.

Shares Outstanding	35.82M
Shares Change (YoY)	+27.51%
Shares Change (QoQ)	+24.13%
Owned by Insiders (%)	19.51%
Owned by Institutions (%)	10.86%
Float	27.87M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	6.91
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.70, with a Debt / Equity ratio of 0.04.

Current Ratio	8.70
Quick Ratio	n/a
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -103.40% and return on invested capital (ROIC) is -94.99%.

Return on Equity (ROE)	-103.40%
Return on Assets (ROA)	-85.00%
Return on Capital (ROIC)	-94.99%
Revenue Per Employee	n/a
Profits Per Employee	-$512,706
Employee Count	17
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Entera Bio has paid $29,000 in taxes.

Income Tax	29,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +95.09% in the last 52 weeks. The beta is 1.60, so Entera Bio's price volatility has been higher than the market average.

Beta (5Y)	1.60
52-Week Price Change	+95.09%
50-Day Moving Average	2.17
200-Day Moving Average	1.30
Relative Strength Index (RSI)	32.66
Average Volume (20 Days)	73,017

Short Selling Information

Short Interest	77,516
Short Previous Month	91,368
Short % of Shares Out	0.22%
Short % of Float	0.28%
Short Ratio (days to cover)	0.74

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-8.78M
Pretax Income	-8.69M
Net Income	-8.72M
EBITDA	-8.63M
EBIT	-8.69M
Earnings Per Share (EPS)	-$0.28

Full Income Statement

Balance Sheet

The company has $9.19 million in cash and $377,000 in debt, giving a net cash position of $8.81 million or $0.25 per share.

Cash & Cash Equivalents	9.19M
Total Debt	377,000
Net Cash	8.81M
Net Cash Per Share	$0.25
Equity (Book Value)	8.86M
Book Value Per Share	0.25
Working Capital	8.63M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$7.56 million and capital expenditures -$6,000, giving a free cash flow of -$7.57 million.

Operating Cash Flow	-7.56M
Capital Expenditures	-6,000
Free Cash Flow	-7.57M
FCF Per Share	-$0.21

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Entera Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-27.51%
Shareholder Yield	-27.51%
Earnings Yield	-14.23%
FCF Yield	-12.36%

Analyst Forecast

The average price target for Entera Bio is $10.00, which is 484.80% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.00
Price Target Difference	484.80%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2